Concepedia

Jason D. Graci

JD

Statistics

Publications

19

Citations

902

H-Index

16

Active since

2002

Affiliations

PTC Therapeutics (United States)(Current)

Pennsylvania State University

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Massachusetts Chan Medical School

MRC Laboratory of Molecular Biology

Jason D. Graci is an author at PTC Therapeutics (United States) specializing in molecular virology, virology, and antiviral pharmacology.

ORCID

Publications per year

2002–2022

19

Publications

19

RNA Virus Population Diversity, an Optimum for Maximal Fitness and Virulence

Victoria Korboukh, Cheri A. Lee, Ashley Acevedo et al. · Journal of Biological Chemistry · 2014 · 103 citations · Full text

, , +14

Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties

Liangxian Cao, Marla Weetall, Christopher R. Trotta et al. · Molecular Cancer Therapeutics · 2018 · 85 citations

, , +14

Small molecule splicing modifiers with systemic HTT-lowering activity

Anuradha Bhattacharyya, Christopher R. Trotta, Jana Narasimhan et al. · Nature Communications · 2021 · 85 citations · Full text

, , +17

The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines

Jeremy Luban, Rachel A. Sattler, Elke Mühlberger et al. · Virus Research · 2020 · 73 citations · Full text

, , +12

Therapeutically Targeting Rna Viruses Via Lethal Mutagenesis

Jason D. Graci, Craig E. Cameron · Future Virology · 2008 · 69 citations

, , +17

1–5 of 19